Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Pulp Therapy vs Vitapex Pulpectomy in Non-vital Primary Molars
NCT04547764Phase 3Completed
- Sponsor
- King Abdulaziz University
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metronidazole, ciprofloxacin, minocycline in pulp necrosis, irreversible pulpitis, sponsored by King Abdulaziz University. Started Jun 2017; status: completed.
02
Drugs
metronidazoleciprofloxacinminocycline
03
Conditions
pulp necrosisirreversible pulpitis
Beyond the preview
Go deeper on NCT04547764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04547764.